Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant protein AT-100 as a therapeutic candidate against COVID-19.
read more
Thursday, September 13, 2012
AIT Bioscience is pleased to announce that Dr.Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, has partnered with the company as a senior research advisor bringing with him an impressive background in biotherapeutic drug ...
read more
Friday, September 04, 2020
Akoya Biosciences announced the expansion of its leadership team with the appointment of two senior leaders with expertise in spatial biology and molecular pathology.
read more
Tuesday, November 30, 2021
Akoya Biosciences, Inc., announced that its Advanced Biopharma Solutions (ABS) laboratory, located in Marlborough, Massachusetts, has received its Certificate of Registration from the Clinical Laboratory Improvement Amendments (CLIA) program, ...
read more
Wednesday, November 08, 2023
limentiv Inc., AcelaBio Inc., and PharmaNest Inc. announced their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence (AI)-enabled digital pathology solutions for metabolic dysfunction-associated ...
read more
Tuesday, January 07, 2014
Alkermes plc (NASDAQ:ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 14/032,736, entitled “Prodrugs of fumarates and their use in treating various diseases....
read more
Alkermes plc (NASDAQ: ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for four of Alkermes’ pipeline candidates for the treatment of central nervous system (CNS) disorders: aripiprazole...
read more
Alkermes plc today announced that it has expanded its senior management team by appointing two industry veterans to newly created roles. Srdjan (Serge) Stankovic, M.D., MSPH, will serve as Senior Vice President of Clinical Development and Medical ...
read more
Allscripts has partnered with Elligo Health Research to assist clinicians to conduct clinical trial studies in their own clinics.
read more
Monday, November 24, 2014
In a unique partnership arrangement, Almac, a global leader in advanced clinical technology and support services for the pharmaceutical and biotech industries, and ESMS, the24/7 medical emergency response service for clinical trials have combined ...
read more
Almac are pleased to announce the launch of their novel “Direct to Patient” shipping service for clinical trials recognising the shift in market trends to introduce as many efficiencies as possible into the management of clinical trials and the ...
read more
Almac is pleased to announce the launch of a mobile optimised version of its website, enabling biotech and pharma clients and prospective customers to access Almac’s content whilst out of the office with only a mobile to hand. The new mobile ready ...
read more
Thursday, August 01, 2013
In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA. ...
read more
Thursday, September 05, 2013
In a dual announcement Almac Discovery Ltd and Queen’s University, Belfast (QUB) have revealed the launch of a formal working partnership between Almac and the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s, and a significant ...
read more
Thursday, August 29, 2013
Amgen and Onyx Pharmaceuticals, Inc. today announced that their Boards of Directors have unanimously approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 ...
read more